Sources | Names Used |
---|---|
CTRPv2 | BRD-K55116708 |
PharmacoGx | BRD-K55116708 |
Database | Identifier |
---|---|
Smiles: | C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)Nc3ccccc3N)Oc4c(NC(=O)Nc5ccccc5)cccc4C1=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRRM1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | LYZ | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | ELF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | TMEM161A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | LRRC29 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | GTF2IRD2B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | CD3E | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | SLC25A42 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
mRNA | FOXI2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | STK33 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |